A First-in-Human Study of BMS-986506 in Participants With Advanced Clear Cell Renal Cell Carcinoma (ccRCC)
Clinical trial NCT07195682 · RECRUITING
Trial details
- NCT number
- NCT07195682
- Sponsor
- Bristol-Myers Squibb
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2026-01-15
- Primary completion
- 2030-05-03
- Enrollment
- 281
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.